This small group session will provide an overview of the QPPV role, and also discuss legal considerations for QPPVs and some practical day to day issues for QPPVs in different company sizes and types. It will be interest to those who need to understand more about the role, those who support the QPPV and those who may be thinking of taking on a QPPV role. It may also be of interest to any new or existing QPPVs who wish to refresh their knowledge.

Workshop Chairs:

Elspeth McIntosh, Director, Castle Pharmacovigilance Limited, United Kingdom

Maria Wishart, Deputy EU Qualified Person for Pharmacovigilance, AstraZeneca, United Kingdom

Anna Pavlou, Counsel, Sidley Austin LLP, Belgium

Separate registration required